Abstract
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia characterized by a block of differentiation at the promyelocytic stage. APL patients respond to pharmacological concentrations of all-trans retinoic acid (RA) and disease remission correlates with terminal differentiation of leukemic blasts. The PML/RAR oncogenic transcription factor is responsible for both the pathogenesis of APL and for its sensitivity to RA. In order to identify physiological targets of RA therapy, we analysed gene expression profiles of RA-treated APL blasts and found 1056 common target genes. Comparing these results to those obtained in RA-treated U937 cell lines revealed that transcriptional response to RA is largely dependent on the expression of PML/RAR. Several genes involved in the control of differentiation and stem cell renewal are early targets of RA regulation, and may be important effectors of RA response. Modulation of chromatin modifying genes was also observed, suggesting that specific structural changes in local chromatin domains may be required to promote RA-mediated differentiation. Computational analysis of upstream genomic regions in RA target genes revealed nonrandom distribution of transcription factor binding sites, indicating that specific transcriptional regulatory complexes may be involved in determining RA response.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alberta JA, Springett GM, Rayburn H, Natoli TA, Loring J, Kreidberg JA and Housman D . (2003). Blood, 101, 2570–2574.
Alcalay M, Meani N, Gelmetti V, Fantozzi A, Fagioli M, Orleth A, Riganelli D, Sebastiani C, Cappelli E, Casciari C, Sciurpi MT, Mariano AR, Minardi SP, Luzi L, Muller H, Di Fiore PP, Frosina G and Pelicci PG . (2003). J. Clin. Invest., 112, 1751–1761.
Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M and Pelicci PG . (2001). Oncogene, 20, 5680–5694.
Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci PG and Nervi C . (1996). Blood, 87, 1939–1950.
Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S and Pelicci PG . (2002). Science, 295, 1079–1082.
Fazi F, Travaglini L, Carotti D, Palitti F, Diverio D, Alcalay M, McNamara S, Miller WH, Lo Coco F, Pelicci PG and Nervi C . (2005). Ongogene, in press.
Finocchiaro G, Parise P, Minardi SP, Alcalay M and Muller H . (2004). Bioinformatics, 20, 3670–3672.
Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Lazar MA, Minucci S and Pelicci PG . (1998). Nature, 391, 815–818.
Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I and Pelicci PG . (1993). Cell, 74, 423–431.
Guo Y, Chan R, Ramsey H, Li W, Xie X, Shelley WC, Martinez-Barbera JP, Bort B, Zaret K, Yoder M and Hromas R . (2003). Blood, 102, 2428–2435.
He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A and Pandolfi PP . (1998). Nat. Genet., 18, 126–135.
Hollander M and Wolfe D . (1999). Nonparametric Statistical Methods, 2nd edn. Wiley: New York.
Hosack DA, Dennis Jr G, Sherman BT, Lane HC and Lempicki RA . (2003). Genome Biol., 4, R70.
Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ and Wang ZY . (1988). Blood, 72, 567–572.
Kamashev D, Vitoux D and De The H . (2004). J. Exp. Med., 199, 1163–1174.
Kel AE, Kel-Margoulis OV, Farnham PJ, Bartley SM, Wingender E and Zhang MQ . (2001). J. Mol. Biol., 309, 99–120.
Lacaud G, Gore L, Kennedy M, Kouskoff V, Kingsley P, Hogan C, Carlsson L, Speck N, Palis J and Keller G . (2002). Blood, 100, 458–466.
Lee KH, Chang MY, Ahn JI, Yu DH, Jung SS, Choi JH, Noh YH, Lee YS and Ahn MJ . (2002). Biochem. Biophys. Res. Commun., 296, 1125–1133.
Leone G, Voso MT, Teofili L and Lubbert M . (2003). Clin. Immunol., 109, 89–102.
Lin RJ, Egan DA and Evans RM . (1999). Trends Genet., 15, 179–184.
Liu TX, Zhang JW, Tao J, Zhang RB, Zhang QH, Zhao CJ, Tong JH, Lanotte M, Waxman S, Chen SJ, Mao M, Hu GX, Zhu L and Chen Z . (2000). Blood, 96, 1496–1504.
Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T and Pelicci PG . (1992). Lancet, 340, 1437–1438.
Meng G, Inazawa J, Ishida R, Tokura K, Nakahara K, Aoki K and Kasai M . (2000). Gene, 242, 59–64.
Minucci S and Pelicci PG . (1999). Semin. Cell Dev. Biol., 10, 215–225.
Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE and Serve H . (2004). Mol. Cell Biol., 24, 2890–2904.
Ohneda O, Ohneda K, Arai F, Lee J, Miyamoto T, Fukushima Y, Dowbenko D, Lasky LA and Suda T . (2001). Blood, 98, 2134–2142.
Park DJ, Vuong PT, de Vos S, Douer D and Koeffler HP . (2003). Blood, 102, 3727–3736.
Quandt K, Frech K, Karas H, Wingender E and Werner T . (1995). Nucleic Acids Res., 23, 4878–4884.
Radtke F, Wilson A, Ernst B and MacDonald HR . (2002). Immunol. Rev., 187, 65–74.
Segalla S, Rinaldi L, Kilstrup-Nielsen C, Badaracco G, Minucci S, Pelicci PG and Landsberger N . (2003). Mol. Cell. Biol., 23, 8795–8808.
Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H and Shinkai Y . (2002). Genes Dev., 16, 1779–1791.
Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES and Golub TR . (1999). Proc. Natl. Acad. Sci. USA, 96, 2907–2912.
Vernell R, Helin K and Muller H . (2003). J. Biol. Chem., 278, 46124–46137.
Wang J and Yen A . (2004). Mol. Cell. Biol., 24, 2423–2443.
Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, Alt FW, Gilliland DG, Golub TR and Orkin SH . (1998). Genes Dev., 12, 2392–2402.
Witcher M, Ross DT, Rousseau C, Deluca L and Miller Jr WH . (2003). Blood, 102, 237–245.
Zheng X, Beissert T, Kukoc-Zivojnov N, Puccetti E, Altschmied J, Strolz C, Boehrer S, Gul H, Schneider O, Ottmann OG, Hoelzer D, Henschler R and Ruthardt M . (2004). Blood, 103, 3535–3543.
Acknowledgements
We are grateful to Roberta Bergomas, Elisa Venturini and Laura Tizzoni for excellent technical support and to Elisabetta Citterio and Lucilla Luzi for helpful discussions. This work was supported by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro) to M Alcalay and PG Pelicci. N Meani and S Licciulli were supported by fellowships from Fondazione Italiana per la Ricerca sul Cancro.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Meani, N., Minardi, S., Licciulli, S. et al. Molecular signature of retinoic acid treatment in acute promyelocytic leukemia. Oncogene 24, 3358–3368 (2005). https://doi.org/10.1038/sj.onc.1208498
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208498
Keywords
This article is cited by
-
Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
Nature Medicine (2014)
-
Notch signaling in acute promyelocytic leukemia
Leukemia (2013)
-
Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation
Leukemia (2010)
-
Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia
Apoptosis (2008)
-
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia
Oncogene (2007)